1.85BMarket Cap
28.13P/E TTM
Sarepta Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Sarepta Therapeutics Inc is 8.24, ranking 97 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 28.13, which is 1213.64% below the recent high of 369.56 and 260.12% above the recent low of -45.04.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.